Management of Refractory Status Epilepticus in an Actively Dying Patient

REFERENCES

• Droney J, Hall E. Status epilepticus in a hospice inpatient setting. J Pain Symptom Manage. 2008;36:97–105.
   Google Scholar
• Juba KM, Weiland D. Seizure management in a complex hospice patient. J Pain PalliatCare Pharmacother. 2010;24:27–32.
   Google Scholar
• Allredge BK, Lowenstein DH. Status epilepticus: new concepts. Curr Opin Neurol 1999;12:183–190.
   Google Scholar
• Shorvon S. The management of status epilepticus. J Neurol Neurosurg Psychiatry. 2001;70(Suppl 2):II22–II27.
   Google Scholar
• English WA, Griffin NJ, Nolan JP. Case report: myoclonus after cardiac arrest: pitfalls in diagnosis and prognosis. Anaesthesia. 2009;64:908–911.
   PubMed Web of Science ®Google Scholar
• National Institute of Neurological Disorders and Stroke. Myoclonus Fact Sheet. Bethesda, MD: National Institutes of Health; July 2012. NIH Publication No. 12-4793.
   Google Scholar
• Wijdicks EF, Parisi JE, Sharbrough FW. Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Ann Neurol. 1994;35:239–243.
   PubMedGoogle Scholar
• Walker M. Status epilepticus: an evidence based guide. BMJ. 2005;331:673–677.
   PubMedGoogle Scholar
• Prasad K, Al-Roomi K, Krishnan PR, Sequeira R. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev. 2005;(4):CD003723.
   Google Scholar
• End-of-Life/Palliative Education Resource Center. Fast Fact and Concept #57; Neuroexcitatory Effects of Opioids: Patient Assessment. Available at: www.eperc.mcw.edu. Accessed March 12, 2014.
   Google Scholar
• End-of-Life/Palliative Education Resource Center. Fast Fact and Concept #58; Neuroexcitatory Effects of Opioids: Treatment. Available at: www.eperc.mcw.edu. Accessed March 12, 2014.
   Google Scholar
• Peberdy MA, Callaway CW, Neumar RW, Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(18 Suppl 3):s768–s786.
   PubMed Web of Science ®Google Scholar
• Golf M, Paice J, Feulner E, Refractory status epilepticus. J Palliat Med. 2004;7:85–88.
   PubMedGoogle Scholar
• Waterhouse EJ, DeLorenzo RJ. Status epilepticus in older patients: epidemiology and treatment options. Drugs Aging. 2001;18:133–142.
   PubMed Web of Science ®Google Scholar
• End-of-Life/Palliative Education Resource Center. Fast Fact and Concept #114; Myoclonus. Available at: www.eperc. mcw.edu. Accessed March 12, 2014.
   Google Scholar
• End-of-Life/Palliative Education Resource Center. Fast Fact and Concept #229; Seizure Management in the Dying Patient. Available at: www.eperc.mcw.edu. Accessed March 12, 2014.
   Google Scholar
• Meierkord H, Boon P, Engelsen B, EFNS guideline on the management of status epilepticus. Eur J Neurol. 2006;13:445–450.
   PubMed Web of Science ®Google Scholar
• Bleck TP. Management approaches to prolonged seizures and status epilepticus. Epilepsia. 1999;40(Suppl 1):S59–S63.
   PubMed Web of Science ®Google Scholar
• Treiman DM, Meyers PD, Walton NY, A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339:792–798.
   PubMed Web of Science ®Google Scholar
• Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia.2002;43: 146–153.
   PubMed Web of Science ®Google Scholar
• Sorel L, Mechler L, Harmant J. Comparative trial of intravenous lorazepam and clonazepam in status epilepticus. Clin Ther. 1981;4:326–336.
   PubMedGoogle Scholar
• Levy RJ, Krall RL. Treatment of status epilepticus with lorazepam. Arch Neurol. 1984;41:605–611.
   Google Scholar
• Vincent FM. Lorazepam in myoclonic seizures after cardiac arrest. Ann Intern Med. 1986;104:586.
   Google Scholar
• Katzung B. Drugs that act in the central nervous system. Basic Clin Pharmacol. 9th Ed. New York: Lange Medical Books/ McGraw Hill, 2004:336–441.
   Google Scholar
• MacDonald RL, McLean MJ. Anticonvulsant drugs: mechanisms of action. In: Delgado-Escueta AV, Ward AA Jr, Woodbury DM, Porter RJ, eds. Advances in Neurology. Volume 44. Basic Mechanisms of the Epilepsies: Molecular and Cellular Approaches. New York: Raven Press; 1986: 713–716.
   Google Scholar
• Kumar A, Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med. 1992;20: 483–488.
   PubMed Web of Science ®Google Scholar
• Bassin S, Smith TL, Bleck TP. Clinical review: status epilepticus. Crit Care. 2002;6:137–142.
   Google Scholar
• Wijdicks EF. Propofol in myoclonus status epilepticus in comatose patients following cardiac resuscitation. J Neurol Neurosurg Psychiatry. 2002;73:94–95.
   Google Scholar
• Stecker MM, Kramer TH, Raps EC, Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia. 1998;39:18–26.
   PubMed Web of Science ®Google Scholar
• Parvianen I, Uusaro A, Kalviainen R, Mervaala E, Ruokonen E. Propofol in the treatment of refractory status epilepticus. Intensive Care Med. 2006;32:1075–1079.
   Google Scholar
• End-of-Life/Palliative Education Resource Center. Fast Fact and Concept #106; Controlled Sedation for Refractory Suffering—Part I. Available at: www.eperc.mcw.edu. Accessed March 12, 2014.
   Google Scholar
• End-of-Life/Palliative Education Resource Center. Fast Fact and Concept #107; Controlled Sedation for Refractory Suffering—Part II. Available at: www.eperc.mcw.edu. Accessed March 12, 2014.
   Google Scholar
• Browne TR, Kugler AR, Eldon MA. Pharmacology and pharmacokinetics of fosphenytoin. Neurology. 1996;46(6 Suppl 1):S24–S28.
   Google Scholar
• Mattson RH. Parenteral antiepileptic/anticonvulsant drugs. Neurology. 1996;46(6 Suppl 1):S8–S13.
   PubMed Web of Science ®Google Scholar
• Shaner DM, McCurdy SA, Herring MO, Gabor AJ. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology. 1988;38:202–207.
   PubMed Web of Science ®Google Scholar
• Fischer JH, Patel TV, Fischer PA. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokinet. 2003;42:33–58.
   PubMed Web of Science ®Google Scholar
• Stirling LC, Kurowska A, Tookman A. The use of phenobarbitone in the management of agitation and seizures at the end of life. J Pain Symptom Manage. 1999;17:363–368.
   Google Scholar